Enrique Infante, MD
Obstetrics & Gynecology · Elkhart, INNPI 1194707117
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,362 of the $41,128 with a category attached, or 64.1%. 35 manufacturers reported payments, led by Johnson & Johnson at 53.7% of the total. 2025 is the largest year on record at $25,582, 6.2 times the $4,097 reported in 2019. Among obstetrics & gynecology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $249.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$22K
- Medical Device Business Services, Inc.$6K
- Intuitive Surgical$6K
- Avanos Medical$3K
- Acessa Health Inc.$2K
- Gynesonics, Inc.$342
- plus $2K from 29 others
What the payments were for
- Consulting fees$26,36264%
- Travel & lodging$6,94617%
- Food & beverage$4,77112%
- Education$3,0007%
- Gifts$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 31 | $22,097 |
| Medical Device Business Services, Inc. | 27 | $6,247 |
| Intuitive Surgical | 16 | $5,689 |
| Avanos Medical | 4 | $3,108 |
| Acessa Health Inc. | 10 | $1,886 |
| Gynesonics, Inc. | 3 | $342 |
| Hologic Sales And Service, LLC | 9 | $242 |
| AbbVie | 8 | $164 |
| Caldera Medical, Inc | 2 | $154 |
| Myovant Sciences Inc. | 4 | $136 |
| Aspira Women's Health Inc | 2 | $113 |
| Organon | 8 | $106 |
| Axonics, Inc. | 1 | $106 |
| Astellas Pharma US Inc | 5 | $102 |
| Bayer | 6 | $82 |
| Applied Medical Resources Corporation | 1 | $66 |
| Amgen | 3 | $46 |
| Meditrina | 3 | $45 |
| Biogen | 2 | $39 |
| Mayne Pharma Commercial LLC | 3 | $38 |
| Coopersurgical, Inc. | 2 | $33 |
| Baxter Healthcare | 1 | $32 |
| Myriad Women's Health, Inc. | 1 | $32 |
| Exeltis, USA Inc. | 2 | $27 |
| Channel Medsystems, Inc. | 1 | $26 |
| Dysis Medical, Inc. | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Minerva Surgical, Inc | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Shield Therapeutics Inc | 1 | $14 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,489
- ON-Q* PUMP AND ACCESSORIES$3,081
- Acessa$1,667
- ETHICON$1,404
- Harmonic$542
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$315
- OVA1$106
- Bulkamid$106
- VISTASEAL$104
How this compares
$41,128 in reported general payments places this provider in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 11 | $8,996 |
| PremarinEstrogens, Conjugated | 22 | $6,781 |
| PremproEstrogen,con/M-Progest Acet | 14 | $6,011 |
| Estradiol | 58 | $3,368 |
| Clobetasol Propionate | 24 | $1,218 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin, Prempro | $15 | $12,79236 claims |
| Astellas Pharma US IncMyrbetriq | $102 | $8,99611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.
Other obstetrics & gynecology in Elkhart
- Rocio AhujaElkhart$11K
- Thalia PachiyannakisElkhart$9K
- Ashley ScottFort Wayne$124K
- Candace WestgateIndianapolis$123K
- Keith RamseyLake Station$116K
- Stefanie FloraCarmel$106K
- Lori DavidsonGreenwood$54K
- Julius Ellisla Porte$53K
- Emmary ButlerWinchester$45K
- Paul MorrisonNewburgh$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.